Firuza Rajesh Parikh

Firuza Rajesh Parikh

Auto-generated profile, based on publicly available information

Firuza Rajesh Parikh

FertilTree-Jaslok International Fertility Centre, Jaslok Hospital, Mumbai, Maharashtra, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Human Reproductive Sciences
Verified
Journal Article
Open access
FPFiruzaRajesh Parikh
FiruzaRajesh Parikh
AAArundhatiSitaram Athalye
ArundhatiSitaram Athalye
NNNandkishorJagannath Naik
NandkishorJagannath Naik
DNDattatrayJayaram Naik
DattatrayJayaram Naik
RSRupeshRamesh Sanap
RupeshRamesh Sanap
PMProchiFali Madon
ProchiFali Madon
Preimplantation genetic testing (PGT) is an early form of prenatal genetic diagnosis where abnormal embryos are identified, thereby allowing transfer of genetically normal embryos. This technology has become an integral part of Assisted Reproductive Technology (ART) procedures. Initial experiments with animals as early as 1890 and those in the mid and later part of the last century paved the forward path of ART and PGT. This review article covers the evolution of PGT and is a pointer toward current and fast-evolving technology, allowing scientists and doctors to better comprehend human reproduction, and ensure healthy pregnancy outcomes.

1 January 2024 in The World Journal of Men's Health
Verified
Journal Article
Open access
PDF file
Rossella CannarellaRossella Cannarella
Rossella Cannarella
RSRupin Shah
Rupin Shah
THTaha Hamoda
Taha Hamoda
FBFlorence Boitrelle
Florence Boitrelle
Ramadan SalehRamadan Saleh
Ramadan Saleh
GFGlobal Andrology Forum
Global Andrology Forum
Cannarella R, et al. World J Mens Health. 2023 Jun;41:e59. https://doi.org/10.5534/wjmh.230034

7 March 2022 in ACS Omega
Verified
Journal Article
Open access
SGSusmita Ghosh
Susmita Ghosh
SPSwapneil Parikh
Swapneil Parikh
MNMehar Un Nissa
Mehar Un Nissa
AAArup Acharjee
Arup Acharjee
ASAvinash Singh
Avinash Singh
FPFiruza Parikh
Firuza Parikh
A considerable section of males suffered from COVID-19, with many experiencing long-term repercussions. Recovered males have been documented to have compromised fertility, albeit the mechanisms remain unclear. We investigated the impact of COVID-19 on semen proteome following complete clinical recovery using mass spectrometry. A label-free quantitative proteomics study involved 10 healthy fertile subjects and 17 COVID-19-recovered men. With 1% false discovery rate and >1 unique peptide stringency, MaxQuant analysis found 1099 proteins and 8503 peptides. Of the 48 differentially expressed proteins between the healthy and COVID-19-recovered groups, 21 proteins were downregulated and 27 were upregulated in COVID-19-recovered males. The major pathways involved in reproductive functions, such as sperm–oocyte recognition, testosterone response, cell motility regulation, adhesion regulation, extracellular matrix adhesion, and endopeptidase activity, were downregulated in COVID-19-recovered patients according to bioinformatics analysis. Furthermore, the targeted approach revealed significant downregulation of semenogelin 1 and prosaposin, two proteins related to male fertility. Therefore, we demonstrate the alteration of semen proteome in response to COVID-19, thus disrupting the male reproductive function despite the patient’s clinical remission. Hence, to understand fertility-related biological processes triggered by this infection, a protracted evaluation of the consequences of COVID-19 in recovered men is warranted.

15 December 2023 in Frontiers in Reproductive Health
Verified
Journal Article
Open access
FPFiruza Parikh
Firuza Parikh
AAArundhati Athalye
Arundhati Athalye
PMProchi Madon
Prochi Madon
MKMeenal Khandeparkar
Meenal Khandeparkar
DNDattatray Naik
Dattatray Naik
AUAnuradha Udumudi
Anuradha Udumudi
Pre-implantation genetic testing (PGT) is a vital tool in preventing chromosomal aneuploidies and other genetic disorders including those that are monogenic in origin. It is performed on embryos created by intracytoplasmic sperm injection (ICSI). Genetic counseling in the area of assisted reproductive technology (ART) has also evolved along with PGT and is considered an essential and integral part of Reproductive Medicine. While PGT has the potential to prevent future progeny from being affected by genetic conditions, genetic counseling helps couples understand and adapt to the medical, psychological, familial and social implications of the genetic contribution to disease. Genetic counseling is particularly helpful for couples with recurrent miscarriages, advanced maternal age, a partner with a chromosome translocation or inversion, those in a consanguineous marriage, and those using donor gametes. Partners with a family history of genetic conditions including hereditary cancer, late onset neurological diseases and with a carrier status for monogenic disorders can benefit from genetic counseling when undergoing PGT for monogenic disorders (PGT-M). Genetic counseling for PGT is useful in cases of Mendelian disorders, autosomal dominant and recessive conditions and sex chromosome linked disorders and for the purposes of utilizing HLA matching technology for creating a savior sibling. It also helps in understanding the importance of PGT in cases of variants of uncertain significance (VUS) and variable penetrance. The possibilities and limitations are discussed in detail during the sessions of genetic counseling.

1 January 2021 in Journal of Human Reproductive Sciences
Verified
Journal Article
Open access
PDF file
FPFiruza R Parikh
Firuza R Parikh
AAArundhati S Athalye
Arundhati S Athalye
DKDhananjaya K Kulkarni
Dhananjaya K Kulkarni
RSRupesh R Sanap
Rupesh R Sanap
SDSuresh B Dhumal
Suresh B Dhumal
PMProchi F Madon
Prochi F Madon
Preimplantation genetic testing (PGT) for monogenic disorders and assisted reproductive technology have evolved and progressed in tandem. PGT started with single-cell polymerase chain reaction (PCR) followed by fluorescent in situ hybridisation for a limited number of chromosomes, later called 'preimplantation genetic diagnosis (PGD) version 1'. This review highlights the various molecular genetic techniques that have evolved to detect specific inherited monogenic disorders in the preimplantation embryo. Literature review in English was performed in PubMed from 1990 to 2021, using the term 'preimplantation genetic diagnosis'. With whole-genome amplification, multiple copies of embryonic DNA were created. This helped in avoiding misdiagnosis caused by allele dropout. Multiplex fluorescent PCR analysed informative short tandem repeats (STR) and detected mutations simultaneously on automated capillary electrophoresis sequencers by mini-sequencing. Comparative genomic hybridisation (CGH) and array CGH were used for 24 chromosome aneuploidy screening. Subsequently, aneuploidies were detected by next-generation sequencing using single-nucleotide polymorphism arrays, while STR markers were used for haplotyping. 'PGD version 2' included accurate marker-based diagnosis of most monogenic disorders and detection of aneuploidy of all chromosomes. Human leukocyte antigen matching of embryos has important implications in diagnosis and cure of haemoglobinopathies and immunodeficiencies in children by means of matched related haematopoietic stem cell transplantation from an unaffected 'saviour sibling' obtained by PGT.

21 January 2024 in F&S Science
Verified
Journal Article
Closed access
FPFiruza Rajesh Parikh
Firuza Rajesh Parikh
SUShonali Uttamchandani
Shonali Uttamchandani
SSSujatha Sawkar
Sujatha Sawkar
MPMadhavi Panpalia
Madhavi Panpalia
NNNandkishor Naik
Nandkishor Naik
RPRajesh Parikh
Rajesh Parikh